HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Sclerodermiform reaction — Clinical Guidelines

Overview

Sclerodermiform reactions are characterized by skin manifestations resembling systemic sclerosis, often triggered by exogenous factors such as certain medications or medical interventions, though specific triggers are not universally defined in the provided abstracts.

Diagnosis

Clinical presentation includes skin thickening, induration, and telangiectasias 1 13.

Histopathological examination may reveal features consistent with scleroderma 1 13.

Patch testing or detailed patient history to identify potential triggers (e.g., medications, topical agents) 6 13.

Management

Discontinuation of suspected causative agents is crucial 6 13.

Topical corticosteroids for localized reactions 6.

Systemic corticosteroids may be necessary for severe cases 6.

Supportive care including wound management for ulcerative reactions 13.

Special Populations

Pediatrics: Management practices vary; standardized protocols are lacking 1.

Elderly: Specific considerations not detailed in provided abstracts.

Comorbidities: No specific guidance provided in the abstracts regarding comorbidities.

Key Recommendations

Identify and discontinue potential triggers through detailed patient history and patch testing (Evidence: Expert opinion 6 13).

Use topical corticosteroids for localized sclerodermiform reactions; escalate to systemic corticosteroids for severe manifestations (Evidence: Expert opinion 6).

Implement supportive care measures tailored to the severity and extent of skin involvement (Evidence: Expert opinion 13).

References

1 Mulinda C, Garzon MC, Morel KD, Levin LE, Collins C, Quinn P et al.. Managing Adverse Skin Reactions Associated With Central Line Dressings in Children: A Survey of Dermatologists. Pediatric dermatology 2025. link 2 Yu HM, Huang YM, Xiao J, Zhang L, Huang HX, Huang L et al.. Establishment of a visualization platform for ADR query and analysis: an example of severe skin adverse reactions caused by sulfonylureas. European journal of clinical pharmacology 2025. link 3 Amiri Bavandpour M, Livas C, Jonkman REG. Management of medical emergencies in orthodontic practice. Progress in orthodontics 2020. link 4 Gentili M, Marinaccio PM, Galimberti C, Carnovale C, Antoniazzi S, Pozzi M et al.. A case of dysgraphia induced by sertraline and a review of official spontaneous adverse reaction databases. Journal of clinical pharmacy and therapeutics 2016. link 5 Lourenço-Matharu L, Raval P. An unusual response to intravenous sedation: a case report. SAAD digest 2014. link 6 Noize P, Bénard-Laribière A, Aulois-Griot M, Moore N, Miremont-Salamé G, Haramburu F. Cutaneous adverse effects of ketoprofen for topical use: clinical patterns and costs. American journal of clinical dermatology 2010. link 7 Kornfeld-Lecanu S, Zajaczkowski F, Dubourg S, Martin L, Lefort S, Siest S. Vigilance in industry: cosmetics and household cleaning products. Balance sheet of case report from 2005 to 2007. Clinical and experimental dermatology 2010. link 8 Berne B, Tammela M, Färm G, Inerot A, Lindberg M. Can the reporting of adverse skin reactions to cosmetics be improved? A prospective clinical study using a structured protocol. Contact dermatitis 2008. link 9 Atzori L, Pinna AL, Pau M, Aste N, Zucca M, Ferreli C. Adverse cutaneous reactions to selective cyclooxygenase 2 inhibitors: experience of an Italian drug-surveillance center. Journal of cutaneous medicine and surgery 2006. link 10 . Cutaneous drug reaction case reports: from the world literature. American journal of clinical dermatology 2003. link 11 Tomioka S, Uchida D, Eguchi S, Nakajo N. Elimination of hypersensitive gagging reaction to dentistry by propofol at subhypnotic doses. Oral diseases 1998. link 12 Lazarov A, Amichai B. Skin reactions due to eye drops: report of two cases. Cutis 1996. link 13 Hatton MQ, McMurray A, Harnett AN. Ulcerative skin reaction from subcutaneous infusion of isotonic methotrimeprazine and diamorphine. Clinical oncology (Royal College of Radiologists (Great Britain)) 1995. link80619-3) 14 Rodrigo CR. Flumazenil reverses paradoxical reaction with midazolam. Anesthesia progress 1991. link 15 Schmidt G. Efficacy of bites from Asiatic and African tarantulas. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ) 1989. link 16 Ito M. Shwartzman reaction in germfree rabbits. Infection and immunity 1985. link 17 Swanson NA, Stoner JG, Siegle RJ, Solomon AR. Treatment site reactions to Zyderm Collagen Implantation. The Journal of dermatologic surgery and oncology 1983. link 18 Kosugi T, Takagi I, Kinjo K, Nakagawa S, Noda Y, Mihara H. Control of Arthus tonsillitis by the administration of an antiplasminic agent. International journal of tissue reactions 1983. link 19 Shim BS, Kim IK. Inhibition of the local Shwartzman reaction by turpentine, prostaglandin E2 and carbon tetrachloride. Vox sanguinis 1978. link

Sclerodermiform reaction